NCT00330577

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (planned)
• Sponsor: Aristotle University Of Thessaloniki · Academic / Other
• Sex: All
• Age: 29 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control, 24-hour blood pressure effect and safety of Latanoprost/Timolol fixed combination given once in the evening with placebo once in the morning versus timolol maleate 0.5% given twice daily in patients with ocular hypertension and primary open-angle glaucoma.

Conditions

• Primary Open Angle Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	timolol maleate 0.5%
DRUG	latanoprost/timolol fixed combination
DRUG	placebo (artificial tears)

Timeline

• Start date: 2006-04-01
• Primary completion: 2007-04-01
• Completion: 2007-07-01
• First posted: 2006-05-29
• Last updated: 2014-05-12

Locations

1 site across 1 country: Greece